Who Can Get Sickle Cell? Populations and Inheritance

Nobody catches sickle cell disease. People are born with it when both parents pass on a changed copy of the same gene. Carrying a single copy is very common and usually harmless, which is why most parents of an affected baby never knew they carried it.

Where the disease clusters is a story about malaria. In places where malaria once ruled, one copy of the gene helped people survive.1Journal of Human Virology & Retrovirology. The protective role of sickle cell trait against Plasmodium falciparum malaria Families with roots across Africa, India, the Middle East and southern Europe carry it most, though migration has now carried it worldwide.2Nature. Epidemiology: A moving target

How Sickle Cell Is Passed From Parents to Children

Sickle cell disease comes from a single-letter change in the beta globin gene. That gene tells the body how to build part of hemoglobin, the protein in red blood cells that carries oxygen.3PubMed. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs The changed version makes a form called hemoglobin S, often written HbS on test reports.3PubMed. Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs

Inside a red cell, hemoglobin S behaves normally while oxygen levels are high. When oxygen drops, the molecules can stick together into stiff strands that bend the cell out of its flexible disc shape. Stiff, curved cells can block small blood vessels and break apart early, which underlies the pain episodes and anemia of the disease.

Everyone has two copies of the gene, and the disease appears only when both copies are the sickle type.4Centre for Genetics Education. Sickle Cell Disease Fact Sheet A person with one sickle copy and one working copy has sickle cell trait and is called a carrier.4Centre for Genetics Education. Sickle Cell Disease Fact Sheet Because that one working copy makes mostly normal hemoglobin, a carrier usually has far fewer problems. The gene sits on chromosome 11, not on a sex chromosome, so males and females are affected equally.4Centre for Genetics Education. Sickle Cell Disease Fact Sheet A parent who has the disease always passes on one sickle copy, so all of their children are at least carriers.

A family can go generations without an affected child if only one parent each time carries the gene. Then two carriers have children, and the disease seems to appear from nowhere.

Sickle cell disease also includes pairing one sickle copy with another changed beta globin gene, such as hemoglobin C or beta thalassemia.5Blood. Hemoglobin S/Chocowinity: A De Novo Compound Beta Globin Heterozygosity Resulting in Severe Sickle Cell Anemia So a parent with hemoglobin C trait or beta thalassemia trait can have a child with the disease if the other parent carries a sickle copy. Rarely, a brand-new gene change found in neither parent combines with an inherited sickle copy to cause severe disease.5Blood. Hemoglobin S/Chocowinity: A De Novo Compound Beta Globin Heterozygosity Resulting in Severe Sickle Cell Anemia

The Odds for Each Child When Parents Carry the Gene

When both parents are carriers, each pregnancy has these chances:

Each carrier passes on one of the two copies, at random, which gives four equally likely combinations. The two mixed combinations give a carrier, which is why that chance is 50%. The odds are set at conception, so nothing a parent does before or during pregnancy changes them.

These chances apply separately to every pregnancy, like a fresh coin toss. Two carriers could have several affected children, or none, by chance. Having one affected child does not make the next three safe, and it does not mean exactly one in four children will be affected. Only testing an embryo or a pregnancy can tell you about a specific child.

Other pairings work out differently:

  • One carrier and one non-carrier: no child has the disease, and about half are carriers.
  • One parent with the disease and one non-carrier: every child is a carrier.
  • One parent with the disease and one carrier: about half of children have the disease and half are carriers.
  • Two parents with the disease: every child has the disease.

What Carrying the Sickle Cell Trait Means for Your Health

People with the trait are generally healthy, though some show mild anemia.4Centre for Genetics Education. Sickle Cell Disease Fact Sheet With one working copy, most red cells stay normal, so everyday life, school, work and sports are usually unaffected. Standard checkups and ordinary blood counts usually do not reveal the trait, and many carriers learn their status only from a newborn screen, a partner’s result or a pregnancy test. The trait is not a mild form of the disease, and it rarely causes pain crises. Carriers do not need regular treatment.

Unlike most carrier states, though, the trait appears to raise the risk of a few complications, including injury from extreme exertion, chronic kidney disease, and blood clots.7PubMed Central. The current state of sickle cell trait: implications for reproductive and genetic counseling

High altitude raises some of these risks. At altitude, carriers had about 3 times the odds of chronic kidney disease and 4 times the odds of a clot in the lung compared with non-carriers.8Haematologica. Adverse clinical outcomes associated with sickle cell trait at high altitude Damage to the spleen from lost blood supply was also far more common in carriers at high altitude, especially in men.8Haematologica. Adverse clinical outcomes associated with sickle cell trait at high altitude A carrier who gets sudden belly pain on the left side at altitude should mention the trait, since this can be mistaken for something needing surgery.9PubMed Central. Splenic syndrome in patients at high altitude with unrecognized sickle cell trait: splenectomy is often unnecessary

Extreme exertion matters too. Hard exercise in heat, dehydration and low oxygen can make a carrier’s red cells sickle more than usual. This can lead to muscle breakdown and, rarely, serious collapse during very intense training. The risk is tied to extreme, sudden effort. Normal exercise is safe and healthy for carriers. Unusual muscle pain, weakness or exhaustion mean stopping, resting and getting help rather than pushing through.

Why Sickle Cell Is Common in Some Ancestries

Carriers have strong protection against severe malaria caused by the deadliest malaria parasite.1Journal of Human Virology & Retrovirology. The protective role of sickle cell trait against Plasmodium falciparum malaria In malaria regions, carriers survived and had children more often than people with no sickle copy or two copies.1Journal of Human Virology & Retrovirology. The protective role of sickle cell trait against Plasmodium falciparum malaria So the gene stayed common even though two copies cause serious disease.

The parasite lives inside red blood cells for part of its life cycle. In carriers, infected cells tend to be cleared quickly or support the parasite poorly, so infections are less likely to become severe. The protection is against severe and fatal illness, not against getting bitten or infected at all.

The gene did not arise just once. Gene patterns point to separate sickle versions named after places in Africa, plus an Arab-Indian version.10PubMed Central. Evolutionary history of sickle-cell mutation: implications for global genetic medicine The version found in India and eastern Saudi Arabia is not seen in Africa, suggesting the change arose separately in Asia.11PubMed Central. Geographical survey of beta S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation In Greece, the gene likely arrived over recent centuries with people from North Africa.12PubMed. The origin of the sickle mutation in Greece; evidence from beta S globin gene cluster polymorphisms

In sub-Saharan Africa, about 1.5% of babies are born with some form of sickle cell disease.13PubMed. Prevalence estimates of sickle cell disease among children and adolescents in sub-Saharan Africa: a systematic review and modelling analysis Among tribal groups in India, between 1 and 40 out of every 100 people are carriers, depending on the group.14PubMed Central. Sickle cell disease in tribal populations in India

Ancestry is a guide, not a rule. Many people have mixed ancestry they may not know about, and white, Hispanic and Asian people can be carriers. Testing, not appearance, gives the answer.

Sickle Cell Is Now Found Worldwide

Migration from Africa and India brought the gene to western Europe, North America and eastern South America.2Nature. Epidemiology: A moving target The number of migrants carrying the sickle gene rose from about 1.6 million in 1960 to 3.6 million in 2000.15PubMed Central. Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000 In England, about 1 in 2,000 newborns screen positive for a significant hemoglobin disorder, five times higher in London.16PubMed Central. Implementation of universal newborn bloodspot screening for sickle cell disease and other clinically significant haemoglobinopathies in England: screening results for 2005–7

Having children with partners from other backgrounds spread it further across ancestries. Over time, people with no known family link to Africa, India or the Mediterranean can carry it, which is why some health systems now offer screening more widely rather than by ancestry alone.

For families in low-risk countries, doctors may not suspect sickle cell if your ancestry is unexpected, so mention your family origins when planning a pregnancy. Universal newborn screening catches cases regardless of background. Both partners should be tested even if only one has high-carrier ancestry, because carrier status can come from a grandparent’s side without any outward sign.

Why Sickle Cell Is Milder in Some People

Fetal hemoglobin, the type made before birth, is the strongest natural factor that eases sickle cell disease.17PubMed Central. Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis Production mostly switches to adult hemoglobin in the first months of life. Fetal hemoglobin does not join the sticky strands that bend red cells, so cells with more of it are less likely to sickle. That explains why babies with the disease are often well for their first months, before levels fall. Levels of fetal hemoglobin are set by many genes and vary between populations.17PubMed Central. Global genetic modifiers of fetal hemoglobin in sickle cell disease: Systematic review and meta-analysis

Inheriting alpha thalassemia alongside sickle cell also changes how the disease behaves.18PubMed Central. Genetic Modifiers of Sickle Cell Disease The same gene can still run a different course. In western India, two groups with similar sickle gene rates had different courses: milder in the tribal group, more severe in the other.19American Journal of Hematology. Effect of α-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India And higher fetal hemoglobin from certain genes did not always mean fewer complications.20Haematologica. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

How to Find Out if You or Your Baby Has the Gene

Carrier screening is a blood test that shows whether you carry a sickle or related gene.21American College of Obstetricians and Gynecologists. Carrier Screening for Hemoglobinopathies: Sickle Cell Disease and Thalassemia Anyone pregnant or thinking of becoming pregnant should be offered it.21American College of Obstetricians and Gynecologists. Carrier Screening for Hemoglobinopathies: Sickle Cell Disease and Thalassemia The lab separates the types of hemoglobin in the blood and reports which are present, and a clinician or counselor explains the result.

Ask your doctor or midwife for a hemoglobinopathy screen, not just a routine blood count, because a routine count can look normal in carriers. Results may list hemoglobin types, with AS meaning trait. If a carrier result appears, your partner’s result is the next question, since the child’s risk depends on both of you, so your partner should be tested too.

Every newborn in the United States is screened for sickle cell disease.22PubMed Central. Prospective Newborn Screening for Sickle Cell Disease and Other Inherited Blood Disorders in Central Malawi Early diagnosis and care have cut sickle cell deaths about tenfold in wealthier countries.23Current Practices in Sickle Cell Disease. Screening of Newborn with Sickle Cell Disease in the View of Resource-Limited Setting In many low-resource regions, though, most affected children die undiagnosed before age 5.24PubMed Central. Point-of-Care Screening for Sickle Cell Disease in Low-Resource Settings: a Multi-Center Evaluation of HemoTypeSC, a Novel Rapid Test

A positive newborn screen is confirmed with a follow-up test. Babies with trait are usually reported so parents know. If nobody tells you your baby’s result, ask for it.

Options When Both Partners Are Carriers

Couples who are both carriers should talk with a genetic counselor or genetics specialist.21American College of Obstetricians and Gynecologists. Carrier Screening for Hemoglobinopathies: Sickle Cell Disease and Thalassemia A counselor reviews both partners’ results and family history and explains the odds and the options below.

Prenatal tests take a small sample of the placenta or of the fluid around the baby, using procedures done at set points in pregnancy. They can show whether the baby has the disease, is a carrier, or has neither copy. Such procedures carry a small risk of miscarriage, which a counselor can explain.

If a child is affected, stem cell transplant can cure the disease, but few patients have a matched brother or sister donor.25PubMed. HLA-Matched Unrelated Donors for Patients with Sickle Cell Disease: Results of International Donor Searches Gene-editing treatments that switch fetal hemoglobin back on have reduced symptoms in early trials.26PubMed Central. CRISPR-Cas9 Editing of the HBG1/HBG2 Promoters to Treat Sickle Cell Disease